India's Extreme Heat Crisis Intensifies as Workers Face Economic and Health Pressures
India is experiencing severe heatwaves with temperatures exceeding 40°C across large regions, forcing millions of workers to choose between income and safety. The country lost an estimated 247 billion potential labour hours in 2024, with informal workers and outdoor laborers most vulnerable to heat stress. Experts warn that emergency measures alone are insufficient and that climate change and urbanization are making heatwaves longer, stronger, and more frequent.
India is grappling with intensifying heatwaves that are taking a significant toll on its workforce and public health. Temperatures in northern and western regions are exceeding 40°C—about 4.5 to 6°C above normal—forcing workers like small business owners and daily-wage earners to navigate impossible choices between closing operations and losing income or continuing to work in dangerous conditions. Research indicates that up to three-quarters of India's workforce is engaged in heat-exposed labor, and the economic impact is substantial: India lost 247 billion potential labour hours in 2024 according to The Lancet. While authorities have implemented heat action plans and cooling centers, experts emphasize that these emergency measures are insufficient. Studies predict India could experience up to 40 additional unusually hot days annually over the next two decades, driven by climate change and rapid urbanization that creates urban heat islands. Medical professionals warn of serious health consequences, with some researchers cautioning that parts of South Asia could eventually face heat and humidity levels approaching the limits of human survival.
What's missing
The article does not provide specific data on heat-related mortality or morbidity rates in India, nor does it detail the specific composition or effectiveness of existing cooling centers and heat action plans beyond brief mentions.
What different sources said
- Channel NewsAsiaCenter
India's extreme heat takes a toll on workers as experts urge long-term solutions
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.